Sridhar Epari

Suggest Changes
Learn More
BACKGROUND & OBJECTIVES Determination of HER2 status in breast cancer has become important to identify potential candidates for anti-HER2 therapy. In this study we compared fluorescence in situ(More)
INTRODUCTION HER2/neu gene status in breast cancers can be evaluated by targeting protein and gene - immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH). Recent studies have(More)